In the News
Mortality benefit of tighter glycemic control may vary by diabetes duration, study finds
Mortality risk increased with worse glycemic control among patients who had had diabetes for less than five years, while a mean HbA1c level between 6.5% to 7.9% was associated with the lowest mortality risk in those who had had the disease longer.
Closed-loop system offers better control than pump with sensor, six-month trial finds
Patients with type 1 diabetes who were randomly assigned to insulin treatment with a closed-loop system spent more time in the target glycemic range than those assigned to a sensor-augmented pump.
Adding weight management to group visits didn't change HbA1c, but improved weight loss, hypoglycemia
Incorporating intensive weight management with a low-carb diet into standard group medical visits for patients with diabetes “should be considered as an alternative, noninferior approach for glycemic management that has additional clinical advantages,” study authors concluded.
MKSAP quiz: Newly diagnosed type 1 diabetes
This month's quiz asks readers to evaluate a 19-year-old man who was diagnosed with type 1 diabetes four months ago. Since starting insulin, his HbA1c level has decreased from 11.1% to 5.0%.
Spotlight on bone density
Recent research quantified vertebral fractures in patients with type 2 diabetes, compared fracture risks of starting sodium-glucose cotransporter-2 inhibitors or dipeptidyl peptidase-4 inhibitors, and measured bone mineral density in patients with type 1 diabetes.
In the Clinic: Type 2 Diabetes
Current evidence on prevention and treatment of type 2 diabetes is summarized in a new In the Clinic article targeted at primary care physicians.
Dapagliflozin reduced cardiorenal outcomes but not MACE in T2 diabetes with or at risk for atherosclerotic CVD
Baseline kidney disease, albuminuria, and cardiovascular disease (CVD) status may help determine which patients will benefit most from sodium-glucose cotransporter-2 inhibitors, according to an ACP Journal Club commentary.
Managing patients with diabetes and heart failure
Conference coverage from the Heart Failure Society of America's annual meeting focuses on patients with both diabetes and heart failure.